Contra-indicated in patients with evidence of vitamin D toxicity or hypercalcemia.
Contra-indicated in patients with evidence of vitamin D toxicity or hypercalcemia.
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of paricalcitol in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 03/13/2024